| Score | |
| CAS | 25013-16-5 |
| eye shadow (62 products) | |
| lipstick (60 products) | |
| lip liner (26 products) | |
| mascara (18 products) | |
| facial moisturizer/ treatment (17 products) | |
| Show all 287 products that contain BHA. | |
| how to read the score | |
image source: PubChem |
| ||||||||||||||||||||
Function/use(s): Antioxidant; Fragrance Ingredient; MASKING
About BHA: BHA (butylated hydroxyanisole) is a preservative and stabilizer; U.S. National Toxicology Program, a part of the National Institutes of Health, has classified BHA as "reasonably anticipated to be ... read more
Synonym(s): ANTIOXYNE B; ANTRANCINE 12; EEC NO. E320; EMBANOX; NIPANTIOX 1-F; PROTEX; SUSTANE 1-F; TENOX BHA
Allergies/immunotoxicity | ||
|---|---|---|
| type of concern | product conditions | reference |
| Known human immune system toxicant | National Library of Medicine HazMap | |
Use restrictions | ||
|---|---|---|
| type of concern | product conditions | reference |
| Violation of government restrictions - Banned or found unsafe for use in cosmetics | EU Banned and Restricted Fragrances | |
Endocrine disruption | ||
|---|---|---|
| type of concern | product conditions | reference |
| Human endocrine disruptor - strong evidence | European Commission on Endocrine Disruption | |
| One or more studies show significant wildlife and the environment disruption | European Commission on Endocrine Disruption | |
| show more | ||
Cancer | ||
|---|---|---|
| type of concern | product conditions | reference |
| Possible human carcinogen | products for use on the lips | California EPA Proposition 65 |
| Possible human carcinogen | products for use on the lips | NTP Report on Carcinogens, 11th Edition |
| Possible carcinogen | Environment Canada Domestic Substance List | |
| Limited evidence of carcinogenicity | products for use on the lips | Int'l Agency for Research on Cancer (IARC) - Carcinogens |
Organ system toxicity (non-reproductive) | ||
|---|---|---|
| type of concern | product conditions | reference |
| Known human toxicant | EU Banned and Restricted Fragrances | |
| Classified as a high human health priority | Environment Canada Domestic Substance List | |
| show more | ||
Persistence and bioaccumulation | ||
|---|---|---|
| type of concern | product conditions | reference |
| Persistent, bioaccumulative in wildlife | OSPAR PBTs - Substances of Possible Concern | |
| show more | ||
Ecotoxicology | ||
|---|---|---|
| type of concern | product conditions | reference |
| Wildlife and environmental toxicity | Illinois EPA Chemicals Associated with Endocrine System | |
| show more | ||
Multiple, additive exposure sources | ||
|---|---|---|
| type of concern | product conditions | reference |
| Designated as safe for general or specific, limited use in food | FDA Food Additive Status | |
| Designated as safe for general or specific, limited use in food | FDA Everything Added to Food | |
Data gaps | ||
|---|---|---|
| type of concern | product conditions | reference |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | Cosmetic Ingredient Review Assessments | |
| 1,946 studies in PubMed science library may include information on the toxicity of this chemical see search results -> | PubMed | |
Government, industry, academic studies and classifications |
||
|---|---|---|
| government/industry list/academic study | appears on list as | classification(s) |
| FDA Food Additive Status | BHA | • AOX/FS • GRAS • 0.02% - Of fat or oil content • incl essential (volatile) oil • or food • incl oleomargarine - Part 166 • Margarine • AOX • REG • 10 ppm • alone or w/BHT - In potato granules - CFR172.110 • 32 ppm - In mixed diced • glazed fruits - CFR172.110 • 50 ppm • alone |
| Cosmetic Ingredient Review Assessments | BHA | QQQ01,QQQ11; C-, D- |
| Cosmetic Ingredient Review Assessments | BUTYLATED HYDROXYANISOLE | QQQ01,QQQ11; C-, D- |
| FDA Everything Added to Food | BUTYLATED HYDROXYANISOLE | • ASP |
| Environment Canada Domestic Substance List | PHENOL, (1,1-DIMETHYLETHYL)-4-METHOXY- | ,,High-Health Priority,,,,Carcinogenic,,, |
| Illinois EPA Chemicals Associated with Endocrine System | TERT-BUTYLHYDROXYANISOLE | EPA: Suspected Endocrine Disruptor |
| European Commission on Endocrine Disruption | TERT.-BUTYLHYDROXYANISOLE (BHA) | HH-CAT1;WF-CAT1 |
| EU Banned and Restricted Fragrances | BHA | Prohibited. Should not be used as a fragrance ingredient. Based on the depigmenting effect (pc to IFRA). |
| IFRA Fragrance Ingredient List | PHENOL, (1,1-DIMETHYLETHYL)-4-METHOXY- | reported as used in fragrance compounds in 2008 |
| National Library of Medicine HazMap | BUTYLATED HYDROXYANISOLE | SS: Yes; |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | BUTYLATED HYDROXYANISOLE (BHA) | IARC GROUP 2B |
| NTP Report on Carcinogens, 11th Edition | BUTYLATED HYDROXYANISOLE (BHA) | Reasonably Anticipated to be a Human Carcinogen |
| Our Stolen Future Endocrine Disruptors | BUTYLATED HYDROXYANISOLE (BHA) | Estrogen |
| OSPAR PBTs - Substances of Possible Concern | (1,1DIMETHYLETHYL)4METHOXYPHENOL | Chemical of Concern under the OSPAR convention |
| California EPA Proposition 65 | BUTYLATED HYDROXYANISOLE | cancer |
| Japanese National Institute of Health Sciences, 1993 | BUTYLATED HYDROXYANISOLE (BHA) | Endocrine Toxicity Hazards: suspected |
Other RTECS® classifications [shown for informational purposes only] |
||
|---|---|---|
| government/industry list/academic study | appears on list as | classification(s) |
| RTECS®- Australian Journal of Experimental Biology and Medical Science 1959 | BHA | • liver - Changes in liver weight (rat TDLo) |
| RTECS®- Australian Journal of Experimental Biology and Medical Science 1961 | BHA | • endocrine system - Changes in adrenal weight (rat TDLo) • blood - Changes in serum composition (eg., TP, bilirubin, cholesterol) (rat TDLo) |
| RTECS®- British Journal of Cancer 1982 | BHA | • liver - Changes in liver weight (mouse TDLo) • biochemical - Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) (mouse TDLo) • liver - Other changes (mouse TDLo) |
| RTECS®- Bulletin of Environmental Contamination and Toxicology 1985 | BHA | • biochemical - Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) (rat TDLo) • liver - Other changes (rat TDLo) |
| RTECS®- Cancer Letters (Shannon, Ireland) 1986 | BHA | • mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (rat orl) |
| RTECS®- Cancer Letters (Shannon, Ireland) 1999 | BHA | • cancer - Active as anti-cancer agent (mouse TDLo) • cancer - Protects against induction of experimental tumors (mouse TDLo) • respiratory - Tumors (mouse TDLo) |
| RTECS®- Cancer Letters (Shannon, Ireland) 1999 | BHA | • cancer - Active as anti-cancer agent (rat TDLo) • cancer - Protects against induction of experimental tumors (rat TDLo) • liver - Tumors (rat TDLo) |
| RTECS®- Cancer Letters (Shannon, Ireland) 1986 | BHA | • mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (rat orl) |
| RTECS®- Cancer Research 1986 | BHA | • cancer - respiratory neoplasms (rat TD) |
| RTECS®- Carcinogenesis (London) 1992 | BHA | • mutagenic - Positive mutation assay: DNA Inhibition ( human hla) |
| RTECS®- Carcinogenesis (London) 1983 | BHA | • cancer - Cells (cultured) transformed (rat TD) • cancer - kidney or renal system tumors (rat TD) |
| RTECS®- Carcinogenesis (London) 1992 | BHA | • mutagenic - Positive mutation assay: DNA Inhibition ( human hla) |
| RTECS®- Federation Proceedings, Federation of American Societies for Experimental Biology 1972 | BHA | • reproductive - Behavioral (mouse TDLo) |
| RTECS®- FEMS Microbiology Letters 1982 | BHA | • mutagenic - Positive mutation assay: Mutation in Micro-organism (other micro-organisms ) |
| RTECS®- FEMS Microbiology Letters 1982 | BHA | • mutagenic - Positive mutation assay: Mutation in Micro-organism (other micro-organisms ) |
| RTECS®- Food and Chemical Toxicology 1986 | BHA | • liver - Changes in liver weight (monkey TDLo) • gastrointestinal - Other changes (monkey TDLo) • biochemical - Other enzymes (monkey TDLo) |
| RTECS®- Food and Chemical Toxicology 2004 | BHA | • liver - Changes in liver weight (rat TDLo) • biochemical - Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) (rat TDLo) • liver - Other changes (rat TDLo) |
| RTECS®- Food and Cosmetics Toxicology 1972 | BHA | • liver - Changes in liver weight (monkey TDLo) • liver - Other changes (monkey TDLo) • biochemical - Phosphatases (monkey TDLo) |
| RTECS®- Food and Cosmetics Toxicology 1965 | BHA | • liver - Changes in liver weight (rat TDLo) • biochemical - Phosphatases (rat TDLo) |
| RTECS®- Gann 1982 | BHA | • cancer - gastrointestinal tumor formations - equivocal (rat TD) • cancer - gastrointestinal tumors (rat TDLo) |
| RTECS®- Gann 1983 | BHA | • cancer - gastrointestinal neoplasms (hamster TD) |
| RTECS®- Japanese Journal of Cancer Research 1986 | BHA | • cancer - gastrointestinal tumor formations - equivocal (mouse TDLo) • cancer - gastrointestinal tumors (hamster TDLo) |
| RTECS®- Japanese Journal of Cancer Research 1986 | BHA | • cancer - gastrointestinal neoplasms (rat TD) |
| RTECS®- Japanese Journal of Cancer Research 1993 | BHA | • mutagenic - endocrine system tumors (rat TD) • cancer - gastrointestinal tumors (rat TD) |
| RTECS®- Journal of the American Oil Chemists' Society 1977 | BHA | • broad systemic - Broad systemic toxicity (rabbit LD50) |
| RTECS®- Journal of the National Cancer Institute 1977 | BHA | • mutagenic - Positive mutation assay: Sister Chromatid Exchange (hamster fbr) |
| RTECS®- Journal of the National Cancer Institute 1977 | BHA | • mutagenic - Positive mutation assay: Sister Chromatid Exchange (hamster fbr) |
| RTECS®- Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho 1970 | BHA | • brain, nervous system, or behavioral effect - Altered sleep time (including change in righting reflex) (mouse LD50) • brain, nervous system, or behavioral effect - Ataxia (mouse LD50) • liver - Changes in liver weight (rat TDLo) • blood - Changes in serum composition (eg., TP, bilirubin, cholesterol) (rat TDLo) • endocrine system - Changes in thyroid weight (rat TDLo) • respiratory - Respiratory stimulation (mouse LD50) |
| RTECS®- Mutation Research 1996 | BHA | • mutagenic - Positive mutation assay: DNA Damage (rat lvr) |
| RTECS®- Mutation Research 2002 | BHA | • mutagenic - Positive mutation assay: DNA Damage (mouse orl) |
| RTECS®- Mutation Research 1996 | BHA | • mutagenic - Positive mutation assay: DNA Damage (rat lvr) |
| RTECS®- Mutation Research 2002 | BHA | • mutagenic - Positive mutation assay: DNA Damage (mouse orl) |
| RTECS®- Neurobehavioral Toxicology and Teratology 1981 | BHA | • reproductive - Growth statistics (rat TDLo) • reproductive - Weaning or lactation index (rat TDLo) |
| RTECS®- Toxicology and Applied Pharmacology 2004 | BHA | • reproductive - Uterus, cervix, vagina (rat TDLo) • endocrine system - Changes in adrenal weight (rat TDLo) • liver - Changes in liver weight (rat TDLo) • endocrine system - Changes in prostate weight (rat TDLo) • endocrine system - Changes in uterine weight (rat TDLo) |
| RTECS®- Toxicology In Vitro 1991 | BHA | • mutagenic - Positive mutation assay: DNA Inhibition (hamster lng) |
| RTECS®- Toxicology In Vitro 1991 | BHA | • mutagenic - Positive mutation assay: DNA Inhibition (hamster lng) |
| RTECS®- Toxicology Letters 2003 | BHA | • biochemical - Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) (rat TDLo) • biochemical - Other transferases (rat TDLo) |
| RTECS®- Toxicology Letters 1985 | BHA | • blood - Hemorrhage (rat LD50) • metabolic - Weight loss or decreased weight gain (rat TDLo) • respiratory - Changes in lung weight (rat TDLo) • blood - Other hemolysis with or without anemia (rat TDLo) |
| RTECS®- Toxicology Letters 1986 | BHA | • cancer - gastrointestinal tumors (rat TD) |
| RTECS®- Toxicology 2005 | BHA | • developmental - Delayed effects (rat TDLo) • reproductive - Mating performance (rat TDLo) • reproductive - Other effects in male (rat TDLo) |
references |
||
|---|---|---|
| government/industry list/academic study | reference | |
| FDA Food Additive Status | FDA (U.S. Food and Drug Administration) 2006. Food Additive Status List. Downloaded from http://www.cfsan.fda.gov/%7Edms/opa-appa.html, Oct 16, 2006. | |
| Cosmetic Ingredient Review Assessments | CIR (Cosmetic Ingredient Review). 2006. CIR Compendium, containing abstracts, discussions, and conclusions of CIR cosmetic ingredient safety assessments. Washington DC. | |
| FDA Everything Added to Food | FDA (U.S. Food and Drug Administration). 2008. EAFUS [Everything Added to Food]: A Food Additive Database. FDA Office of Food Safety and Applied Nutrition. | |
| Environment Canada Domestic Substance List | EC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry. | |
| Illinois EPA Chemicals Associated with Endocrine System | Illinois EPA (Illinois Environmental Protection Agency). 2000. Preliminary list of chemicals associated with endocrine system effects in animals and humans (*) or in vitro (+). In EPA (U.S. Environmental Protection Agency) 2000. Handbook for Non-Cancer Health Effects Valuation, Appendix C. | |
| European Commission on Endocrine Disruption | EU (European Union)- Strategy for Endocrine Disrupters 2007. Commision on endocrin disruption requested by the European Parliament in 1998. | |
| EU Banned and Restricted Fragrances | SCCPNFP (Scientific Committee On Cosmetic Products And Non-Food Products). 1999. Opinion Concerning Fragrance Allergy In Consumers. . SCCNFP/0017/98 Final, December 1999; and SCCPNFP (Scientific Committee On Cosmetic Products And Non-Food Products). 2000. An Initial List Of Perfumery Materials Which Must Not Form Part Of Fragrances Compounds Used In Cosmetic Products. SCCNFP/0320/00, final May 2000. | |
| IFRA Fragrance Ingredient List | IFRA (International Fragrance Assocication). 2010. IFRA Fragrance Ingredient List based on 2008 Use Survey. Accessed online 01/04/2010: http://www.ifraorg.org/Home/News/Latest-News/page.aspx/66?xf_itemId=43&xf_selectionDatapartId=25 | |
| National Library of Medicine HazMap | NLM (National Library of Medicine). 2006. HazMap — Occupational Exposure to Hazardous Agents. | |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | IARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures). | |
| NTP Report on Carcinogens, 11th Edition | NTP (National Toxicology Program). 2005. Report on Carcinogens, Eleventh Edition; U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. | |
| Our Stolen Future Endocrine Disruptors | Colborn T, D Dumanoski, JP Myers. 2006. Widespread Pollutants with Endocrine-disrupting Effects. Updated from original listing in "Our Stolen Future" (1996). | |
| OSPAR PBTs - Substances of Possible Concern | OSPAR (Oslo-Paris). 2002. OSPAR List of Substances of Possible Concern. Secondary OSPAR List of Substances of Possible Concern. Secondary OSPAR. Place Published, OSPAR Convention for the Protection of the Marine Environement of North-East Atlanic. | |
| California EPA Proposition 65 | California EPA (California Environmental Protection Agency). 9/2008. Office of Environmental Health Hazard Assessment. Safe Drinking Water and Toxic Enforcement Act of 1986. Chemicals known to the State to cause cancer or reproductive toxicity. | |
| Scorecard.org Toxicity Information | Japanese National Institute of Health Sciences. Lists of Paradigmatic Chemicals. http://www.nihs.go.jp/hse/endocrine-e/paradigm/paradigm.html, World Wildlife Fund. Our Stolen Future. Widespread Pollutants with Endocrine-disrupting Effects. http://www.ourstolenfuture.org/Basics/chemlist.htm. The WWF list is derived from references detailed at http://www.ourstolenfuture.org/Sources/chemsources.htm and was originally published in: Colborn, T., F.S. vom Saal, and A.M. Soto. Developmental Effects of Endocrine-Disrupting Chemicals In Wildlife and Humans. Environmental Health Perspectives 101(5): 378-384. 1993. | |
| RTECS®- Australian Journal of Experimental Biology and Medical Science 1959 [shown for informational purposes only] | RTECS®- Australian Journal of Experimental Biology and Medical Science. (Adelaide, S.A., Australia) V.1-64, 1924-86. 37,533,1959 | |
| RTECS®- Australian Journal of Experimental Biology and Medical Science 1961 [shown for informational purposes only] | RTECS®- Australian Journal of Experimental Biology and Medical Science. (Adelaide, S.A., Australia) V.1-64, 1924-86. 39,353,1961 | |
| RTECS®- British Journal of Cancer 1982 [shown for informational purposes only] | RTECS®- British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- 45,935,1982 | |
| RTECS®- Bulletin of Environmental Contamination and Toxicology 1985 [shown for informational purposes only] | RTECS®- Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- 34,787,1985 | |
| RTECS®- Cancer Letters (Shannon, Ireland) 1986 [shown for informational purposes only] | RTECS®- Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 33,119,1986 | |
| RTECS®- Cancer Letters (Shannon, Ireland) 1999 [shown for informational purposes only] | RTECS®- Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- 137,123,1999 | |
| RTECS®- Cancer Letters (Shannon, Ireland) 1999 [shown for informational purposes only] | RTECS®- Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- 143,173,1999 | |
| RTECS®- Cancer Letters (Shannon, Ireland) 1986 [shown for informational purposes only] | RTECS®- Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- 33,119,1986 | |
| RTECS®- Cancer Research 1986 [shown for informational purposes only] | RTECS®- Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- 46,165,1986 | |
| RTECS®- Carcinogenesis (London) 1992 [shown for informational purposes only] | RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- 13,2389,1992 | |
| RTECS®- Carcinogenesis (London) 1983 [shown for informational purposes only] | RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- 4,895,1983 | |
| RTECS®- Carcinogenesis (London) 1992 [shown for informational purposes only] | RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 13,2389,1992 | |
| RTECS®- Federation Proceedings, Federation of American Societies for Experimental Biology 1972 [shown for informational purposes only] | RTECS®- Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. 31,596,1972 | |
| RTECS®- FEMS Microbiology Letters 1982 [shown for informational purposes only] | RTECS®- FEMS Microbiology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 14,183,1982 | |
| RTECS®- FEMS Microbiology Letters 1982 [shown for informational purposes only] | RTECS®- FEMS Microbiology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 14,183,1982 | |
| RTECS®- Food and Chemical Toxicology 1986 [shown for informational purposes only] | RTECS®- Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- 24,1197,1986 | |
| RTECS®- Food and Chemical Toxicology 2004 [shown for informational purposes only] | RTECS®- Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- 42,899,2004 | |
| RTECS®- Food and Cosmetics Toxicology 1972 [shown for informational purposes only] | RTECS®- Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. 10,769,1972 | |
| RTECS®- Food and Cosmetics Toxicology 1965 [shown for informational purposes only] | RTECS®- Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. 3,457,1965 | |
| RTECS®- Gann 1982 [shown for informational purposes only] | RTECS®- Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. 73,332,1982 | |
| RTECS®- Gann 1983 [shown for informational purposes only] | RTECS®- Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. 74,459,1983 | |
| RTECS®- Japanese Journal of Cancer Research 1986 [shown for informational purposes only] | RTECS®- Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- 77,1083,1986 | |
| RTECS®- Japanese Journal of Cancer Research 1986 [shown for informational purposes only] | RTECS®- Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- 77,854,1986 | |
| RTECS®- Japanese Journal of Cancer Research 1993 [shown for informational purposes only] | RTECS®- Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- 84,237,1993 | |
| RTECS®- Journal of the American Oil Chemists' Society 1977 [shown for informational purposes only] | RTECS®- Journal of the American Oil Chemists' Society. (Champaign, IL) V.24-56, 1947-79. 54,239,1977 | |
| RTECS®- Journal of the National Cancer Institute 1977 [shown for informational purposes only] | RTECS®- Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. 58,1635,1977 | |
| RTECS®- Journal of the National Cancer Institute 1977 [shown for informational purposes only] | RTECS®- Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. 58,1635,1977 | |
| RTECS®- Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho 1970 [shown for informational purposes only] | RTECS®- Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- 22,231,1970 | |
| RTECS®- Mutation Research 1996 [shown for informational purposes only] | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 368,59,1996 | |
| RTECS®- Mutation Research 2002 [shown for informational purposes only] | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 519,103,2002 | |
| RTECS®- Mutation Research 1996 [shown for informational purposes only] | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 368,59,1996 | |
| RTECS®- Mutation Research 2002 [shown for informational purposes only] | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 519,103,2002 | |
| RTECS®- Neurobehavioral Toxicology and Teratology 1981 [shown for informational purposes only] | RTECS®- Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. 3,321,1981 | |
| RTECS®- Toxicology and Applied Pharmacology 2004 [shown for informational purposes only] | RTECS®- Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- 197,230,2004 | |
| RTECS®- Toxicology In Vitro 1991 [shown for informational purposes only] | RTECS®- Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 5,549,1991 | |
| RTECS®- Toxicology In Vitro 1991 [shown for informational purposes only] | RTECS®- Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- 5,549,1991 | |
| RTECS®- Toxicology Letters 2003 [shown for informational purposes only] | RTECS®- Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 145,281,2003 | |
| RTECS®- Toxicology Letters 1985 [shown for informational purposes only] | RTECS®- Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 27,15,1985 | |
| RTECS®- Toxicology Letters 1986 [shown for informational purposes only] | RTECS®- Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 31(Suppl),207,1986 | |
| RTECS®- Toxicology 2005 [shown for informational purposes only] | RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- 208,49,2005 | |
"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.